Our results demonstrate the therapeutic potential of targeting NFAT1-MDM2 pathway and provide new insights into MDM2 targeting strategies, suggesting that InuA may be a novel therapeutic agent for the treatment and prevention of human breast cancer. The gene discussed is MDM2; the disease is breast cancer.